Maxygen Company Profile

07:40 EST 15th December 2018 | BioPortfolio

Maxygen is focused on the development of superior versions of validated major protein pharmaceuticals for the patients who need them. Our lead product candidates address substantial market opportunities in infectious disease, hemostasis and cancer. We are well positioned for growth with a number of excellent product candidates and the financial strength to drive them forward through clinical development.In 1997, Maxygen was founded on the observation that nature has a powerful means of improving upon previous generations through the iterative process of evolution and breeding. We have industrialized this evolutionary process by developing a series of technologies designed to improve specific properties of genes and proteins to create more effective therapies to treat disease.
Maxygen’s portfolio of technologies include our MolecularBreeding™ directed evolution platform and our expertise in PEGylation and directed glycosylation techniques. These technologies help us to improve biological properties of proteins and optimize dosing regimens to create more effective protein pharmaceuticals


301 Galveston Drive
Redwood City
United States of America


Phone: 650-298-5300
Fax: 650-364-2715

News Articles [3 Associated News Articles listed on BioPortfolio]

Maxygen Appoints Steven B. Riedmuller as Chief Executive Officer

SUNNYVALE, CA Sept , 18th 2018 – Maxygen, a provider of high quality services to clients in synthetic biology, metabolic engineering, gene therapy, immunotherapy, and gene editing through applicatio...

Maxygen Receives Milestone Payment in Pfizer Collaboration

Maxygen, Inc. (Redwood City, CA) received a milestone payment from Pfizer Inc. (New York)...

Maxygen Liceses Directed Evolution Technology from CalTech

Maxygen, Inc. (Redwood City, CA) has obtained an exclusive worldwide license from the California Institute of Technology (Pasadena) for the Staggered Extension Process (StEP) directed evolution techno...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [4 Associated Companies listed on BioPortfolio]

Maxygen, Inc.

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs through both internal development and external collaborations and other arrangement...

Maxygen Incorporated

Headquartered in Redwood City, California, Maxygen is a leading biotechnology company focused on creating novel products using its portfolio of integrated proprietary technologies for a broad range of...


Maxygen is focused on the development of superior versions of validated major protein pharmaceuticals for the patients who need them. Our lead product candidates address substantial market opportunit...

CMEA Ventures

CMEA Ventures is a San Francisco based venture capital firm that was established in 1989 and specializes in high technology, life sciences, and alternative energy investments. We invest in both early ...

More Information about "Maxygen" on BioPortfolio

We have published hundreds of Maxygen news stories on BioPortfolio along with dozens of Maxygen Clinical Trials and PubMed Articles about Maxygen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Maxygen Companies in our database. You can also find out about relevant Maxygen Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Corporate Database Quicklinks

Searches Linking to this Company Record